Remdesivir Can Be Used As Schedule Drug On Covid-19 Patients

By -
Reports have been coming in from CDCSO (Central Drug Control Standard Organisation).  As per reports CDCSO has given permission to use Remdesivir to be used on emergency cases in hospitals.

Gilead's Sciences have been given permission for marketing authorisation of its drug Remdesivir only for its emergency restricted use on hospitalized covid-19 patients.

This decision has been given after the widespread outbreak of covid-19 in India.  

As per reports this drug may be given as an injection use on the prescribed medical prescription of a doctor only for hospital use.

This is a prescribed medical drug which can be used on the patients of covid-19 which may be adult or Child.

Comments

  1. Elena wesley2 June 2020 at 16:24

    Thanks for sharing! good to see someone is posting quality information. Its quite different from other posts. If u looking for more updates about coronavirus, visit
    Coronavirus Updates

    ReplyDelete

Post a Comment

Popular posts from this blog

Tiktok shutdown in india: company stop its business in india, more than 2000 employees are unemployed.

By -
Image
after the boarder dispute with china, government of india impose a unstable ban on tiktok, now government stop the ways of tiktok to be back in india.tiktok have more than 200 million active users in india.global head of company give this shutdown information by his email.                                       chinese company bytedance has announced that the company stop its business in india. company take this decision after 7 months long ban by the government. tiktok's global interim head venesha papas and global business solution vise president Blake chandly give this information to there employees by email. before ban in india tiktok had 20 crore active users.    tiktok spokesperson said that we want to continue our business with india and we had put many efforts to talk with government but we dont get any clear guideline by the government that's why we decided to s...
Read more

Media and Entertainment sector lower downs 24% in 2020 despite last-quarter rebound

By -
Image
  India's media and entertainment (M&E) sector lower downed 24% to Rs1.38 trillion in 2020 due to the corona-virus pandemic. The contractions came despite a rebound in the last-quarter. The M&E sector is supposed to expand 25% to Rs1.73 trillion in 2021 and compound annual growth rate of 13.7% to Rs2.23 trillion by 2023, according to a joint report by the Federation of Indian Chambers of Commerce and Industry(Ficci) and EY, finance consulting firm.  While advertisement revenues dropped 25% to 19,900 crore and subscriptions fell 20% to 15,400 crores. Digital advertisement remained unchanged, but print (Rs 8,400 crore) and television (Rs 6,900 crore) advertising saw the steepest declines. The only segments that rose in 2020 were digital and online gaming, which added a total of Rs 2,600 crore and their contribution to the M&E sector rose from 16% in 2019 to 23% in 2020.
Read more

How Does Pushpa Impossible Actress Garima Parihar Balance Life And Work?

By -
Image
1) What do you think about Pushpa Impossible as a show and the character that you are playing? What was your reaction when you were approached? Pushpa Impossible is a show that encourages people from all genders to live optimistically, surviving against obstacles in front of them. This show demonstrates impressive courage and determination through Pushpa, who struggles throughout to support her children after her husband is absconding. She never gave up in the face of adversity, and this same energy is passed onto our audience.  When I was approached by the makers of the show to do the character of Dipti, I was excited. For a long time, I was engaged in negative roles, and I wished to do something positive like the current role of Dipti.  The character of Dipti is bright, mature and has clarity about life. I am happy about doing this character since her maturity really teaches me a lot about handling situations. Undoubtedly, I am growing as an actor in this role and more as...
Read more